At Bristol Gregg had realized that a protein called the microsomal triglyceride transfer protein (MTP) had gone defective in his old patients, and he set out to come up with a drug that blocked it in heart disease patients.
FORBES: How A Mourning Entrepreneur And A Dogged Doctor Rescued A Rare Disease Drug